Theranica

An adult and child wearing the Nerivio device.
Theranica receives FDA 510(k) for migraine prevention device
By Emily Olsen | 11:16 am | March 01, 2023
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
A person wearing an armband with the Theranica device while holding a smartphone.
Theranica raises $45M for migraine digital therapeutic
By Emily Olsen | 01:33 pm | August 29, 2022
The startup plans to use the funding to expand in the U.S.
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine.
Theranica’s migraine DTx receives FDA clearance for adolescent use
By Mallory Hackett | 12:46 pm | January 25, 2021
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine.   
Israeli startup MDClone lands $26m in Series B funding
By Leontina Postelnicu | 09:20 am | August 23, 2019
The round was led by health tech and life sciences VC fund aMoon. 
Working towards a future where people can live (and die) healthy
By Dean Koh | 02:45 am | July 16, 2019
 An interview with Tomoko Inoue, CEO of OMRON Ventures.
Building a future of safe and drug-free alternatives to painkillers
By Dean Koh | 12:14 am | June 17, 2019
Pain is usually an indication something wrong with the body and the typical approach to pain is to take appropriate medicine that will help alleviate that pain.
FDA grants De Novo clearance to smartphone-controlled acute migraine-relief device
By Dean Koh | 11:40 pm | May 28, 2019
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced on May 28 that the U.
Omron Ventures joins Theranica’s Series B funding round as strategic investor
By Dean Koh | 05:35 am | May 14, 2019
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced that Omron Ventures has joined its $35M series B funding round, which was announced earlier this March.
Israel-based Theranica raises $35M in series B funding
By Dean Koh | 01:02 am | March 19, 2019
Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC.